OpenNeedle Ask your own

Question explored with the scientific record

Started from a private conversation ↓

Is it normal if the face gets all red

Sep 13, 2026 · 3 sources used · OpenNeedle synthesis
Facial redness from a 0.6 mg/h nitroglycerin patch is a known, common effect of the drug itself, not necessarily a sign of danger.

Nitroglycerin works by widening blood vessels. That widening reaches the skin of the face, causing flushing and redness. The evidence here shows this is a predictable effect. In a study of pregnant women using a nitroglycerin patch, 75% got headaches [2], and headache is the same vasodilation mechanism reaching the brain's blood vessels. The same widening that causes the headache also reddens the face. A hand-angiography study found that 16 of 25 patients given intra-arterial nitroglycerin developed facial erythema (redness) [3]. That is a direct measure: the drug dilates facial vessels.

The redness is not a skin allergy in most cases. A true allergic skin reaction at the patch site is possible but rare. One case report describes a woman who developed a spreading rash called erythema multiforme at the patch site, confirmed by biopsy [1]. That rash was itchy, widespread, and lasted days. Simple facial flushing from vasodilation fades when the patch comes off.

The dose matters for how intense the flushing is. A 0.6 mg/h patch is a standard starting dose for angina. The evidence does not test that exact dose for facial redness, but the mechanism is dose-dependent: more drug, more vessel widening, more redness. If the redness is mild and goes away when you remove the patch, it is the drug working. If it is painful, spreading, or accompanied by swelling or blistering, that is a different problem.

My call: facial redness at 0.6 mg/h is a normal drug effect, not an emergency, unless it spreads beyond flushing or includes skin damage. Confidence: high.

Keep digging

Sources used 3

  1. Erythema‐multiforme‐like eruption on the application site of a nitroglycerin patch, followed by widespread erythema multiforme Contact Dermatitis (2001) Thin

    This case report describes a 61-year-old woman who developed an erythema-multiforme-like eruption at the site of a nitroglycerin patch, which was confirmed through patch testing and histological examination.

    DOI: 10.1034/j.1600-0536.2001.450512.x
  2. Effect of transdermal nitroglycerin patch on severe preeclamptic women with abnormal Doppler indices International Journal of Reproduction, Contraception, Obstetrics and Gynecology (2019) primary study Strong

    In pregnant women with hypertensive disorder, a 50-mg transdermal GTN patch significantly decreased maternal blood pressure, did not change cerebral circulation pulsatility index, and caused headache in 75% of patients; two cases required treatment interruption.

    DOI: 10.18203/2320-1770.ijrcog20190291
  3. Comparison of the Vasodilating Effect of Nitroglycerin, Verapamil, and Tolazoline in Hand Angiography Journal of Vascular and Interventional Radiology (2003) Thin

    Prospective within-subject comparison in 25 hand-artery angiography patients showing intraarterial verapamil and tolazoline provide greater vasodilation than nitroglycerin, with verapamil offering the best adverse effect profile, supporting its use to optimize peripheral hand va…

    DOI: 10.1097/01.RVI.0000079984.80153.5E

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question